Gallbladder cancer, a vanishing disease?

Cancer Causes and Control

Volumn 23, Issue 10, 2012, Pages 1705-1709

  Alexander, S ^a   Lemmens, V E P P ^b   Houterman, S ^a   Nollen, L ^c   Roumen, R ^a   Slooter, G D ^a  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

Gallbladder cancer; Incidence; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; FEMALE; GALLBLADDER CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STANDARDIZED INCIDENCE RATIO; TREND STUDY;

ADULT; AGED; AGED, 80 AND OVER; CHOLECYSTECTOMY; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; REGISTRIES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866985500     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0049-0     Document Type: Article

References (39)

1. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S et al (2009) Epidemiology of biliary tract cancers: an update. Ann Oncol 20(1):146-159
2. Varshney S, Butturini G, Gupta R (2002) Incidental carcinoma of the gallbladder. Eur J Surg Oncol 28(1):4-10
3. Saika K, Matsuda T (2007) Comparison of time trends in gallbladder cancer incidence (1973-1997) in East Asia, Europe and the USA, from cancer incidence in five continents vols IV-VIII. Jpn J Clin Oncol 37(12):974-976
4. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765-781
5. Available from: www.ikcnet.nl
6. Cubertafond P, Gainant A, Cucchiaro G (1994) Surgical treatment of 724 carcinomas of the gallbladder. Results of the french surgical association survey. Ann Surg 219(3):275-280
7. Kayahara M, Nagakawa T (2007) Recent trends of gallbladder cancer in Japan: an analysis of 4, 770 patients. Cancer 110(3):572-580
8. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ (1993) Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 22(3):369-376
9. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) (1997) Cancer incidence in five continents, vol VII. IARC Scientific Publications No. 143, Lyon, IARC
10. Harmer MH (1978) TNM classification of malignant tumours, 3rd edn. International Union Against Cancer, Geneva
11. Globocan 2008 (2008) World health organization. Available from: http://globocan.iarc.fr/
12. Hoogendoorn D (1988) Remarkable changes in the epidemio-logical pattern of gallstone disease and gallbladder cancer. Ned Tijdschr Geneeskd 132(27):1243-1248
13. Kiran RP, Pokala N, Dudrick SJ (2007) Incidence pattern and survival for gallbladder cancer over three decades-an analysis of 10301 patients. Ann Surg Oncol 14(2):827-832
14. Barakat J, Dunkelberg JC, Ma TY (2006) Changing patterns of gallbladder carcinoma in New Mexico. Cancer 106(2):434-440
15. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II et al (2001) Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51(6):349-364
16. van der Hoeven J, Busch O, Bijnen C, Gouma D, van Gulik T (2010) Diagnosis and treatment of carcinoma of the gall bladder. Ned Tijdschr Geneeskd 154:A355
17. Fujita N, Noda Y, Kobayashi G, Kimura K, Yago A (1999) Diagnosis of the depth of invasion of gallbladder carcinoma by EUS. Gastrointest Endosc 50(5):659-663
18. Legorreta AP, Silber JH, Costantino GN, Kobylinski RW, Zatz SL (1993) Increased cholecystectomy rate after the introduction of laparoscopic cholecystectomy. JAMA 270(12):1429-1432
19. Ahlberg J, Bergstrand LO, Sahlin S (1984) Changes in gallstone morbidity in a community with decreasing frequency of chole-cystectomies. A statistical study of the county of Stockholm, Sweden, 1969-1982. Acta Chir Scand Suppl 520:53-58
20. Diehl AK, Beral V (1981) Cholecystectomy and changing mortality from gallbladder cancer. Lancet 2(8239):187-189
21. Statistics Netherlands CBS Statline. Available from: www.cbs.nl
22. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR et al (2005) Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 128(4):1023-1033
23. Leong RW, Sung JJ (2002) Review article: helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16(6):1037-1045
24. Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ et al (2010) Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 46(6):1101-1110
25. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S et al (2007) Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Hel-icobacter pylori status. Gut 56(7):918-925
26. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345(11):784-789
27. Pinheiro PS, van der Heijden LH, Coebergh JW (1999) Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Laurén type and subsite. Int J Cancer 84(1):28-32
28. Belzer C, Kusters JG, Kuipers EJ, van Vliet AH (2006) Urease induced calcium precipitation by Helicobacter species may initiate gallstone formation. Gut 55(11):1678-1679
29. Maurer KJ, Rao VP, Ge Z, Rogers AB, Oura TJ, Carey MC et al (2007) T-cell function is critical for murine cholesterol gallstone formation. Gastroenterology 133(4):1304-1315
30. Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4(9):695-706
31. Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB et al (2007) Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 56(7):934-940
32. Fong Y, Jarnagin W, Blumgart LH (2000) Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 232(4):557-569
33. Dixon E, Vollmer CM Jr, Sahajpal A, Cattral M, Grant D, Doig C et al (2005) An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 241(3):385-394
34. Zhu AX, Hong TS, Hezel AF, Kooby DA (2010) Current management of gallbladder carcinoma. Oncologist 15(2):168-181
35. Thomas MB (2008) Targeted therapies for cancer of the gallbladder. Curr Opin Gastroenterol 24(3):372-376
36. Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75(1 Suppl):171-190
37. Aldridge MC, Bismuth H (1990) Gallbladder cancer: the polyp-cancer sequence. Br J Surg 77(4):363-364
38. Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K et al (2010) National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg 14(10):1578-1591
39. Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK et al. (2009) Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 144(5):441-447. Discussion 7